AIDS Researcher Emerges as Top Candidate to Head CDC

Robert Redfield would replace Brenda Fitzgerald, who resigned in January over unresolved conflicts of interest.

Written byAshley Yeager
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, DANIEL MAYERUpdate (March 21): Redfield was selected to lead the CDC today. He is expected to be sworn in and start as director in just a few days, according to The Washington Post.

Update (March 20): Past allegations of research misconduct by Redfield are resurfacing, Kaiser Health News reports. In 1994, the Army acknowledged accuracy issues with Redfield's HIV vaccine research, but did not reprimand him for misconduct. A whistleblower, who pointed out the issues back then, is now speaking publicly about them and raising concerns about the Trump administration's vetting process.

Robert Redfield, a leading AIDS researcher who works at the University of Maryland School of Medicine, has emerged as the top choice for director of the Centers for Disease Control and Prevention (CDC). He would replace Brenda Fitzgerald who resigned in late January after it was discovered she bought tobacco, pharmaceutical, and health insurance company stock shares early in her tenure as director. President Donald Trump’s ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other positions. She holds a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT. Ashley edits the Scientist to Watch and Profile sections of the magazine and writes news, features, and other stories for both online and print.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies